News
New Sementis CEO to Advance Vaccine Technology
September 2023 Biotechnology company Sementis will advance its position at the forefront of vaccine technology with the...
-
-
News
GOOD NEWS FLASH
January 2023 Sementis has exciting news. We’re pleased to announce that we’ve been awarded a $3 million Federal...
-
News
Key steps to advance vaccine manufacturing technology
December 2022 Sementis are grateful and proud to have the support of DMTC Ltd to advance research and development...
-
News
Sementis’ quest for an Australian second-generation COVID-19 vaccine
October 2021 A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a...
-
News
New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses
September 2021 Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust...
-
Report
$5.2 million raised to accelerate work on Australian Covid-19 vaccine
MEDIA RELEASE August 2021 Australian biotechnology company Sementis Limited has raised more than $5.2 million to accelerate...
-
News
Adelaide company Sementis will raise $10m to progress its Covid-19 vaccine candidate
August 2021 Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19...
-
Report
Australia accelerates new COVID-19 vaccine to fight mutant strains
MEDIA RELEASE May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government...
-
Report
New Director to Support COVID Vaccine Development at Sementis
April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna...
-
Report
NHMRC Ideas Grant to support the development UniSA-Sementis peanut allergy vaccine
MEDIA RELEASE December 2020 Researchers at UniSA and Sementis are moving a step closer to developing a vaccine...